| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Weber Barbara is a Chief Executive Officer at Tango Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $47.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | TNGX Tango Therapeutics, Inc. | Chief Executive Officer | Sell | 18,791 | $3.07 | $57,710.36 | -0.6% | -62.4% | +256.7% | |
| Oct 8, 2024 | RVMD Revolution Medicines, Inc. | Director | Sell | 5,200 | $48.02 | $249,716.48 | -28.5% | -11.9% | -3.9% | |
| Feb 7, 2024 | TNGX Tango Therapeutics, Inc. | Chief Executive Officer | Sell | 9,138 | $12.59 | $115,051.98 | -0.3% | -38.3% | -74.4% | |
| Sep 1, 2023 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 15,000 | $35.07 | $526,000.50 | -48.7% | -33.4% | +21.6% | |
| Feb 4, 2021 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 5,000 | $50.35 | $251,766.97 | -52.5% | - | - | |
| Feb 2, 2021 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 5,336 | $45.00 | $240,120.00 | -74.7% | - | - | |
| Dec 30, 2020 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 5,336 | $40.95 | $218,529.92 | -58.9% | - | - | |
| Oct 5, 2020 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 10,000 | $35.88 | $358,793.66 | -64.8% | - | - | |
| Aug 13, 2020 | RVMD Revolution Medicines, Inc. | Director | Sale+OE | 2,000 | $28.00 | $56,000.00 | -35.6% | - | - |